Fortaleza Asset Management’s Alnylam Pharmaceuticals ALNY Stock Holding History

Fortaleza Asset Management’s Portfolio ALNY Stock Details ALNY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-35	Closed	-$2.37K	–	186
2016 Q3	$2.37K	Hold	35	–	–	﹤0.01%	192
2016 Q2	$2K	Sell	35 -22,590	-100%	-$1.42M	﹤0.01%	182
2016 Q1	$1.42M	Buy	22,625 +7,895	+54%	+$525K	0.9%	49
2015 Q4	$1.39M	Buy	14,730 +1,365	+10%	+$127K	0.84%	49
2015 Q3	$1.07M	Hold	13,365	–	–	0.76%	48
2015 Q2	$1.6M	Sell	13,365 -6,780	-34%	-$810K	0.96%	46
2015 Q1	$2.1M	Sell	20,145 -6,715	-25%	-$680K	1.19%	26
2014 Q4	$2.6M	Sell	26,860 -20,310	-43%	-$1.88M	1.19%	17
2014 Q3	$3.68M	Buy	47,170 +33,830	+254%	+$2.18M	1.73%	4
2014 Q2	$843K	Buy	13,340 +2,710	+25%	+$161K	0.39%	113
2014 Q1	$714K	Sell	10,630 -5,025	-32%	-$389K	0.36%	102
2013 Q4	$1.01M	Buy	15,655 +5,401	+53%	+$322K	0.51%	71
2013 Q3	$656K	Buy	+10,254	New	+$511K	0.34%	117

Other funds holding ALNY

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

SPC

Slate Path Capital New York $7.22B AUM 110.75% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Fortaleza Asset Management's ALNY Position: Q4 2016 in Review

Fortaleza Asset Management sold out of Alnylam Pharmaceuticals (ALNY) in Q4 2016, closing a stake of 35 shares — an estimated $2.37K sold.

Fortaleza Asset Management first reported a position in ALNY in Q3 2013 and held it in 13 quarters. The position peaked at $3.68M in Q3 2014. 211 funds tracked by Wall St. Rank hold ALNY as of Q4 2016.

Fortaleza Asset Management reported no remaining Alnylam Pharmaceuticals position as of Q4 2016 after selling out during the quarter.
Fortaleza Asset Management sold 35 Alnylam Pharmaceuticals shares in Q4 2016, an estimated $2.37K.
Fortaleza Asset Management first reported a position in Alnylam Pharmaceuticals in Q3 2013 and held it in 13 quarters.
Fortaleza Asset Management's Alnylam Pharmaceuticals position peaked at $3.68M in Q3 2014.
211 funds tracked by Wall St. Rank held Alnylam Pharmaceuticals as of Q4 2016.

Based on Fortaleza Asset Management's 13F filing for Q4 2016, filed 16 Feb 2017.